| P2093 | author name string | Wang P | |
| | Glueck CJ | |
| | Sieve-Smith L | |
| | Tracy T | |
| | Lang JE | |
| P2860 | cites work | Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man | Q26776977 |
| | Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group | Q27860882 |
| | Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group | Q29547282 |
| | Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus | Q29616284 |
| | Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction | Q29618673 |
| | Central obesity, insulin resistance, syndrome X, lipoprotein(a), and cardiovascular risk in Indians, Malays, and Chinese in Singapore | Q33704490 |
| | Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome | Q40864746 |
| | Hyperinsulinaemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study, 15-year follow-up | Q41157353 |
| | Metabolic abnormalities in hypertension | Q41571024 |
| | Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance | Q42021393 |
| | Epidemiologic aspects of lipid abnormalities | Q44963369 |
| | Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease | Q47286354 |
| | Individuals with high total cholesterol/HDL cholesterol ratios are insulin resistant | Q47972709 |
| | Anticardiolipin antibodies in clinical conditions associated with a risk of thrombotic events | Q47988430 |
| | Leptin is involved in gender-related differences in insulin sensitivity. | Q50849692 |
| | Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. | Q50864806 |
| | Computed axial tomographic scan measurement of abdominal fat distribution and its correlation with anthropometry and insulin secretion in healthy Asian Indians. | Q50931416 |
| | The metabolic significance of leptin in humans: gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure. | Q50962458 |
| | Relationships between lipoprotein(a), lipids, apolipoproteins, basal and stimulated fibrinolytic regulators, and D-dimer. | Q51057862 |
| | Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study. | Q51568729 |
| | Progression of coronary artery disease in young male post-infarction patients is linked to disturbances of carbohydrate and lipoprotein metabolism and to impaired fibrinolytic function. | Q51570350 |
| | Factors of the insulin resistance syndrome in nondiabetic and diabetic elderly Japanese-American men. | Q51571020 |
| | Relationships of abdominal obesity and hyperinsulinemia to angiographically assessed coronary artery disease in men with known mutations in the LDL receptor gene. | Q51571062 |
| | Hyperinsulinemia and cardiovascular disease in elderly men: the Honolulu Heart Program. | Q51571137 |
| | Metformin therapy is associated with a decrease in plasma plasminogen activator inhibitor-1, lipoprotein(a), and immunoreactive insulin levels in patients with the polycystic ovary syndrome. | Q51576091 |
| | Heritability of factors of the insulin resistance syndrome in women twins. | Q51577526 |
| | Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus. | Q51578788 |
| | Insulin resistance as an independent risk factor for carotid wall thickening. | Q51579378 |
| | Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators. | Q51581413 |
| | Hyperinsulinemia as an independent risk factor for ischemic heart disease. | Q51581884 |
| | How good a marker is insulin level for insulin resistance? | Q51600914 |
| | The natural history of impaired glucose tolerance in the Pima Indians. | Q51623599 |
| | Gender differences in insulin-stimulated glucose utilization among African-Americans. | Q54192276 |
| | Estimates of in vivo insulin action in man: comparison of insulin tolerance tests with euglycemic and hyperglycemic glucose clamp studies. | Q54361021 |
| | Banting lecture 1988. Role of insulin resistance in human disease | Q55921416 |
| | Anti-cardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men | Q72369034 |
| | Evidence that homocysteine is an independent risk factor for atherosclerosis in hyperlipidemic patients | Q72382548 |
| | Antibodies against cardiolipin and oxidatively modified LDL in 50-year-old men predict myocardial infarction | Q73965948 |
| | The new pathophysiology of coronary artery disease | Q77709273 |
| | Lipoprotein(a) interactions with lipid and non-lipid risk factors in patients with early onset coronary artery disease: results from the NHLBI Family Heart Study | Q77714432 |
| | Evidence that anticardiolipin antibodies are independent risk factors for atherosclerotic vascular disease | Q77769404 |
| P433 | issue | 11 | |
| P921 | main subject | cardiovascular disease | Q389735 |
| | hyperlipidemia | Q1079120 |
| | atherosclerosis | Q12252367 |
| P304 | page(s) | 1437-1444 | |
| P577 | publication date | 1999-11-01 | |
| P1433 | published in | Metabolism | Q15764354 |
| P1476 | title | Contribution of fasting hyperinsulinemia to prediction of atherosclerotic cardiovascular disease status in 293 hyperlipidemic patients. | |
| P478 | volume | 48 | |